2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
June 28th 2022
Florida Cancer Specialists & Research Institute welcomes Board-certified medical oncologist Richard McDonough, MD to the statewide practice.
June 24th 2022
Florida Cancer Specialists & Research Institute clinicians and leaders shared the latest advances in oncology pharmacy operations and dispensing practices at the National Community Oncology Dispensing Association 2022 Spring Forum held last month in Atlanta.
June 21st 2022
Florida Cancer Specialists & Research Institute, LLC has opened a new state-of-the-art facility at 8981 Colonial Center Drive in Fort Myers to provide comprehensive treatments and a variety of services to adults with cancer and other diseases.
June 13th 2022
Martin Dietrich, MD, PhD, of Florida Cancer Specialists, has been named the 2022 Man of the Year by the Orlando Chapter of the Leukemia & Lymphoma Society.
June 9th 2022
Medical oncologist Ibrahim Sadek, MD has joined Florida Cancer Specialists & Research Institute.
June 1st 2022
Each May during Oncology Nursing Month, Florida Cancer Specialists & Research Institute, LLC recognizes two outstanding nurses within the practice.
May 24th 2022
Medical oncologist Michael Diaz, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC, is the recipient of the Florida Society of Clinical Oncology Dorothy Green Phillips Legacy Award 2022.
May 10th 2022
The American Cancer Society reported earlier this year that the risk of dying from cancer in the United States has decreased by 32% over the past 28 years, which translates to almost 3.5 million fewer cancer deaths.
April 25th 2022
Two medical oncologists from Florida Cancer Specialists & Research Institute participated in the Florida Society of Clinical Oncology Fellow & Resident Educational Training Program. The program featured respected keynote speakers to share helpful information for transitioning into the oncology workforce.
April 4th 2022
Florida Cancer Specialists & Research Institute launched a new website to host a variety of top articles ranging from recent oncology and hematology studies to new therapies, even topics on value-based care.
March 31st 2022
Margarett Ellison, MD, gynecologic oncologist with Gynecologic Oncology of Tallahassee, A Division of Florida Cancer Specialists & Research Institute, has been designated as a National GYN Oncology Observation Site for Intuitive Surgical.
March 28th 2022
Florida Cancer Specialists and Research Institute welcomed Ken Sturtz, MBA, MHA to its executive leadership team as Chief Information Officer.
March 10th 2022
Joshua Eaves joined the Florida Cancer Specialists & Research Institute senior management team as senior vice president, corporate development.
February 22nd 2022
Skill, passion and teamwork. Essential elements for patient centered partnerships.
February 15th 2022
The survival rate for Americans diagnosed with several of the most common cancers has increased dramatically in the past nearly three decades, thanks in large part to scientific discoveries and treatment advances.
January 20th 2022
Florida Cancer Specialists Nurse Receives Inaugural MBC Heroes™ Award from CURE Media Group.
November 12th 2021
Florida Cancer Specialists & Research Institute, in collaboration with AdventHealth Heart of Florida and Central Florida Cancer Institute, has received a three-year accreditation from the National Accreditation Program for Breast Centers, a quality program of the American College of Surgeons.
October 22nd 2021
Three medical oncologists at Florida Cancer Specialists & Research Institute are co-authors on a new integrated safety analysis of umbralisib, used to treat lymphoid malignancies.
October 15th 2021
Michael Diaz, MD will assume the role of President & Managing Physician at Florida Cancer Specialists & Research Institute.
August 27th 2021
Since 2016, Florida Cancer Specialists & Research Institute has been a national leader in the transition of oncology care from a fee-for-service reimbursement structure to fee-for-value.